Embryo Attrition Rate Calculator

Calculate the expected attrition rate of embryos during IVF treatment based on clinical parameters. This tool helps estimate potential outcomes at different stages of embryo development.

Comprehensive Guide to Embryo Attrition Rates in IVF

Embryo attrition is a natural part of the in vitro fertilization (IVF) process, where not all fertilized eggs develop into viable embryos suitable for transfer or freezing. Understanding attrition rates helps patients set realistic expectations and clinicians optimize treatment protocols.

What is Embryo Attrition?

Embryo attrition refers to the progressive loss of embryos at various stages of development during IVF treatment. This occurs through several mechanisms:

• Failed fertilization: Not all retrieved eggs fertilize successfully (typically 70-80% fertilization rate)
• Developmental arrest: Some embryos stop growing at cleavage stages (Day 2-3)
• Blastulation failure: Cleavage-stage embryos may not develop into blastocysts
• Genetic abnormalities: Many embryos have chromosomal anomalies detected through PGT testing
• Freeze-thaw survival: Not all frozen embryos survive the thawing process

Typical Attrition Rates by Developmental Stage

Developmental Stage	Typical Attrition Rate	Primary Causes
Fertilization (Day 1)	20-30%	Failed sperm-egg fusion, activation issues
Cleavage Stage (Day 3)	10-20%	Developmental arrest, fragmentation
Blastocyst Formation (Day 5-7)	30-50%	Failed cavitation, metabolic issues
PGT Testing (if performed)	40-60%	Chromosomal abnormalities detected
Freeze-Thaw Cycle	5-10%	Cellular damage during cryopreservation

Factors Affecting Embryo Attrition Rates

Maternal Age

The most significant factor, with attrition rates increasing dramatically after age 35:

• <35 years: ~50% total attrition
• 35-37 years: ~60% total attrition
• 38-40 years: ~70% total attrition
• >40 years: ~80%+ total attrition

Clinic Laboratory Quality

Top-tier clinics demonstrate:

• 20-30% higher blastulation rates
• 15-20% better euploid rates
• 10% better freeze-thaw survival

Key quality indicators include air quality systems, embryo scope usage, and experienced embryologists.

Genetic Factors

Both partners’ genetics influence:

• Aneuploidy rates (especially maternal)
• Mitotic potential of embryos
• Response to ovarian stimulation

PGT testing can identify viable embryos but also increases observed attrition through selective elimination.

Strategies to Minimize Embryo Attrition

1. Optimized Stimulation Protocols: Tailored medication regimens to produce high-quality oocytes while avoiding ovarian hyperstimulation syndrome (OHSS).
2. Advanced Culture Systems: Time-lapse incubators and specialized media formulations that mimic in vivo conditions more closely.
3. Preimplantation Genetic Testing: While PGT increases immediate attrition by eliminating aneuploid embryos, it improves overall success rates by selecting viable embryos.
4. Blastocyst Culture: Extended culture to Day 5-7 allows for better selection of developmentally competent embryos.
5. Vitrification Techniques: Ultra-rapid freezing methods that improve post-thaw survival rates to >95% in many clinics.
6. Lifestyle Optimization: Preconception health improvements including:
• Folic acid and CoQ10 supplementation
• Smoking cessation and alcohol reduction
• Body weight optimization (BMI 19-25)
• Stress management techniques

Interpreting Your Attrition Rate Results

The calculator provides personalized estimates based on:

1. Initial Cohort Size: More fertilized eggs provide better statistical chances but don’t guarantee more viable embryos.
2. Developmental Milestones: Each stage (Day 3, Day 5, PGT results) represents a critical selection point.
3. Cumulative Attrition: The product of attrition rates at each stage gives the overall likelihood of obtaining a euploid blastocyst.
4. Clinical Context: Your specific diagnosis (e.g., DOR, male factor) may affect actual outcomes.

Comparison of Attrition Rates by Age Group (Based on SART 2021 Data)

Age Group	Avg. Eggs Retrieved	Fertilization Rate	Blastulation Rate	Euploid Rate	Cumulative Attrition
<35 years	12.4	78%	58%	52%	68%
35-37 years	10.8	76%	52%	41%	75%
38-40 years	9.1	74%	45%	28%	82%
41-42 years	6.7	70%	38%	15%	89%
>42 years	4.2	65%	30%	8%	94%

When to Seek Second Opinions

Consider consulting additional specialists if you experience:

• Repeated fertilization failure (<50% fertilization in multiple cycles)
• Consistent poor blastulation rates (<30% of fertilized eggs)
• No euploid embryos after multiple retrievals
• Significant discrepancies between expected and actual attrition rates

Potential underlying issues may include:

• Sperm DNA fragmentation (test with TUNEL or COMET assay)
• Immunological factors (NK cell testing, TH1/TH2 ratios)
• Metabolic disorders (mitochondrial DNA testing)
• Laboratory quality issues (consider clinic audit)

Emerging Technologies Reducing Attrition

Cutting-edge research is developing new methods to improve embryo viability:

1. AI Embryo Selection: Machine learning algorithms (like Life Whisperer or EmbryoScope with AI) that analyze time-lapse images to predict viability with up to 90% accuracy.
2. Mitochondrial Transfer: Experimental techniques to replace defective mitochondrial DNA in oocytes (currently in clinical trials).
3. Metabolomic Profiling: Non-invasive analysis of embryo culture media to identify viable embryos based on metabolic byproducts.
4. Gene Editing: CRISPR-based correction of specific genetic mutations in embryos (ethical and technical challenges remain).
5. Artificial Wombs: Advanced culture systems that more closely mimic uterine conditions for extended development.

Psychological Impact of Embryo Attrition

The emotional toll of embryo attrition is often underestimated. Patients report:

• “Grief for potential lives” even at early stages
• Guilt or self-blame regarding lifestyle factors
• Anxiety about “wasting” financial resources
• Strain on relationships from repeated disappointments

Coping strategies include:

• Counseling with fertility-specific therapists
• Support groups (RESOLVE.org offers excellent resources)
• Mindfulness and stress-reduction techniques
• Setting incremental goals rather than focusing solely on pregnancy outcomes

Frequently Asked Questions About Embryo Attrition

Why do so many embryos arrest during development?

Embryonic arrest typically occurs due to:

1. Chromosomal abnormalities: The most common cause, accounting for ~60% of attrition. Human embryos have remarkably high aneuploidy rates compared to other mammals.
2. Metabolic deficiencies: Inadequate energy production in embryonic cells, often linked to mitochondrial dysfunction.
3. Epigenetic errors: Failures in gene expression programming during early divisions.
4. Culture stress: Suboptimal laboratory conditions (pH, oxygen levels, temperature fluctuations).
5. Programmed cell death: Apoptosis of compromised cells that would not support viable development.

Does a high attrition rate mean poor egg quality?

Not necessarily. While poor egg quality can contribute to higher attrition, several other factors play significant roles:

• Sperm quality: DNA fragmentation in sperm is increasingly recognized as a major contributor to embryonic arrest.
• Laboratory conditions: Even high-quality eggs may fail in suboptimal culture environments.
• Genetic compatibility: Some couples have higher rates of embryonic incompatibilities.
• Age-related factors: Older eggs have higher aneuploidy rates regardless of other quality markers.

A single cycle with high attrition doesn’t definitively indicate poor egg quality. Patterns across multiple cycles are more informative.

Can lifestyle changes improve embryo attrition rates?

While genetics and age are the primary determinants, certain lifestyle modifications can optimize embryonic development:

Lifestyle Factor	Potential Impact	Recommended Action	Timeframe for Effect
Diet (Mediterranean pattern)	10-15% improvement in blastulation	High antioxidants, omega-3s, folate	3+ months pre-retrieval
CoQ10 Supplementation	Improved mitochondrial function	300-600mg daily	2-3 months
Smoking Cessation	Up to 30% reduction in aneuploidy	Complete cessation	3+ months
Alcohol Reduction	5-10% better fertilization	<2 drinks/week	1-2 months
Exercise (moderate)	Improved uterine receptivity	150 min/week brisk activity	Ongoing
Stress Management	Potential 5-10% improvement	Mindfulness, therapy	Ongoing

How accurate are PGT results in predicting embryo viability?

Preimplantation Genetic Testing (PGT) has revolutionized embryo selection but has important limitations:

• Accuracy: Modern PGT-A (for aneuploidy) has >98% accuracy for chromosomal abnormalities it tests for.
• Limitations:
  • Cannot detect all genetic issues (e.g., single gene disorders unless specifically tested)
  • Mosaicism (mix of normal/abnormal cells) can lead to false positives/negatives
  • Doesn’t assess mitochondrial quality or other viability factors
• Clinical Impact:
  • Increases live birth rates per transfer by 10-20%
  • Reduces miscarriage rates by ~50%
  • May require more cycles to obtain euploid embryos
• Controversies:
  • Some studies suggest PGT may not improve outcomes for all patient groups
  • Potential for over-reliance on genetic testing at expense of morphological assessment
  • Ethical concerns about embryo selection and disposal

Authoritative Resources on Embryo Attrition

For additional reliable information, consult these expert sources:

1. Society for Assisted Reproductive Technology (SART) – Publishes annual clinic-specific success rate data and patient education resources. Their Patient’s Guide to ART includes detailed explanations of embryo development and attrition.
2. CDC Assisted Reproductive Technology Reports – The U.S. government’s official repository of IVF success rates, including age-specific attrition data. Their interactive data tools allow comparison of clinic performance.
3. American Society for Reproductive Medicine (ASRM) – Professional organization that publishes clinical guidelines. Their patient education arm (ReproductiveFacts.org) offers excellent resources on embryo development and testing.
4. European Society of Human Reproduction and Embryology (ESHRE) – International organization with comprehensive guidelines on embryo culture and selection. Their embryo assessment guidelines are considered gold standard.